MedMij:V1.0 AddendaInhoudelijkeGegevens: verschil tussen versies
Naar navigatie springen
Naar zoeken springen
k |
|||
Regel 38: | Regel 38: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_1_MA_1 | + | |style="background-color: white;"|MBH_513_1_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
Regel 47: | Regel 47: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geannuleerd indicator | |colspan="3"|Geannuleerd indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|True |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 82: | Regel 82: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_1_MA_2 | + | |style="background-color: white;"|MBH_513_1_MA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
Regel 91: | Regel 91: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Bertine van | + | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 123: | Regel 123: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_2_MA_2 | + | |style="background-color: white;"|MBH_513_2_MA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
Regel 135: | Regel 135: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Hans van | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 170: | Regel 170: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_3_MA_1 | + | |style="background-color: white;"|MBH_513_3_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
Regel 182: | Regel 182: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Hans van | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 217: | Regel 217: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_4_MA_1 | + | |style="background-color: white;"|MBH_513_4_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
Regel 226: | Regel 226: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 272: | Regel 272: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_2_VV_2 | + | |style="background-color: white;"|MBH_513_2_VV_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Datum | |colspan="3"|Datum | ||
Regel 278: | Regel 278: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"|Hans van | + | |style="background-color: white;"|Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Te verstrekken hoeveelheid | |colspan="3"|Te verstrekken hoeveelheid | ||
Regel 290: | Regel 290: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toelichting | |colspan="3"|Toelichting | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Nog in te vullen, zie word... |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie naar medicatieafspraak | |colspan="3"|Relatie naar medicatieafspraak | ||
Regel 306: | Regel 306: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_4_VV_1 | + | |style="background-color: white;"|MBH_513_4_VV_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Datum | |colspan="3"|Datum | ||
Regel 312: | Regel 312: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Te verstrekken hoeveelheid | |colspan="3"|Te verstrekken hoeveelheid | ||
Regel 345: | Regel 345: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_1_TA_1 | + | |style="background-color: white;"|MBH_513_1_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
Regel 354: | Regel 354: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geannuleerd indicator | |colspan="3"|Geannuleerd indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|True |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekker | |colspan="3"|Verstrekker | ||
Regel 389: | Regel 389: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_2_TA_1 | + | |style="background-color: white;"|MBH_513_2_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
Regel 433: | Regel 433: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_4_TA_1 | + | |style="background-color: white;"|MBH_513_4_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
Regel 482: | Regel 482: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_2_MVE_1 | + | |style="background-color: white;"|MBH_513_2_MVE_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Aanschrijfdatum | |colspan="3"|Aanschrijfdatum | ||
Regel 510: | Regel 510: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_4_MVE_1 | + | |style="background-color: white;"|MBH_513_4_MVE_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Datum | |colspan="3"|Datum | ||
Regel 549: | Regel 549: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_2_MGB_1 | + | |style="background-color: white;"|MBH_513_2_MGB_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
Regel 555: | Regel 555: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|True |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
Regel 561: | Regel 561: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Hans van | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
Regel 583: | Regel 583: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"|Zorgverlener: | + | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
Regel 596: | Regel 596: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_2_MGB_2 | + | |style="background-color: white;"|MBH_513_2_MGB_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
Regel 602: | Regel 602: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|True |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
Regel 608: | Regel 608: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Hans van | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
Regel 630: | Regel 630: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Informant | |colspan="3"|Informant | ||
− | |style="background-color: white;"|Persoon: | + | |style="background-color: white;"|Persoon: M. XXX_Amaya - Mantelzorger. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"|Zorgverlener: | + | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
Regel 646: | Regel 646: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_2_MGB_3 | + | |style="background-color: white;"|MBH_513_2_MGB_3 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
Regel 652: | Regel 652: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|True |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
Regel 677: | Regel 677: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Informant | |colspan="3"|Informant | ||
− | |style="background-color: white;"|Zorgverlener: | + | |style="background-color: white;"|Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"|Zorgverlener: | + | |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
Regel 693: | Regel 693: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_5132_2_MGB_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2018-08-16T20:59:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|True |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 2018-08-16T00:00:00, gedurende 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
Regel 712: | Regel 712: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, gedurende 1 dag, 1 maal | + | |style="background-color: white;"|Vanaf 2018-08-16T00:00:00, gedurende 1 dag, Vanaf T, gedurende 1 dag, 1 maal daags 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 737: | Regel 737: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_3_MGB_1 | + | |style="background-color: white;"|MBH_513_3_MGB_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
Regel 743: | Regel 743: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|True |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
Regel 749: | Regel 749: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Hans van | + | |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
Regel 784: | Regel 784: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"|MBH_513_4_MGB_1 | + | |style="background-color: white;"|MBH_513_4_MGB_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
Regel 790: | Regel 790: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|True |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Volgens afspraak indicator | |colspan="3"|Volgens afspraak indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|False |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
Regel 833: | Regel 833: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgegevens | |colspan="3"|Naamgegevens | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Pauline P. XXX_Bourgonje |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Patient identificatienummer | |colspan="3"|Patient identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999911296 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Patient identificatienummer | |colspan="3"|Patient identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|12102 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geboortedatum | |colspan="3"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 aug 1964 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geslacht | |colspan="3"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') |
|}<section end=XXX_Bourgonje /> | |}<section end=XXX_Bourgonje /> | ||
===Medicatieafspraken XXX_Bourgonje === | ===Medicatieafspraken XXX_Bourgonje === | ||
Regel 857: | Regel 857: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_123_1_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 7 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 875: | Regel 872: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-StandaardGPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order, Zo nodig 2 maal daags aanbrengen, op de huid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zo nodig 2 maal per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_123_1 |
− | |} | + | |}<section end=MA_XXX_Bourgonje /> |
+ | ===Verstrekkingsverzoeken XXX_Bourgonje === | ||
+ | <section begin=VV_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 901: | Regel 903: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_123_1_VV_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T- 7 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|100 gram |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-StandaardGPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Beoogd verstrekker |
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_123_1_MA_1 |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_123_1 |
− | |} | + | |}<section end=VV_XXX_Bourgonje /> |
+ | ===Toedieningsafspraken XXX_Bourgonje === | ||
+ | <section begin=TA_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 942: | Regel 936: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_123_1_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T- 7 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, tot nader order | + | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot nader order, | + | |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order, Zo nodig 2 maal daags aanbrengen, op de huid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zo nodig 2 maal per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_123_1_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_123_1 |
− | |} | + | |}<section end=TA_XXX_Bourgonje /> |
+ | ===Verstrekkingen XXX_Bourgonje === | ||
+ | <section begin=MVE_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 989: | Regel 982: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_123_1_MVE_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T- 7 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekte hoeveelheid |
− | + | |style="background-color: white;"|100 gram | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Relatie naar verstrekkingsverzoek | |
− | + | |style="background-color: white;"|MBH_123_1_VV_1 | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan=" | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_123_1 |
− | |} | + | |}<section end=MVE_XXX_Bourgonje /> |
+ | ===Medicatiegebruik XXX_Bourgonje === | ||
+ | <section begin=MGB_XXX_Bourgonje /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.036: | Regel 1.012: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_123_1_MGB_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2018-08-12T20:58:00 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 2018-08-11T00:00:00, gedurende 2 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Geneesmiddel | |
− | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-StandaardGPK') | |
− | |||
− | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_123_1_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_123_1 |
− | |}<section end= | + | |}<section end=MGB_XXX_Bourgonje /> |
− | == | + | ==Patiënt J. XXX_Cnossen== |
− | <section begin= | + | <section begin=XXX_Cnossen /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.090: | Regel 1.057: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|J. XXX_Cnossen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Patient identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|999911740 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Patient identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|31105 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|4 aug 1964 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geslacht | ||
+ | |style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') | ||
+ | |}<section end=XXX_Cnossen /> | ||
+ | ===Medicatieafspraken XXX_Cnossen === | ||
+ | <section begin=MA_XXX_Cnossen /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_313_1_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 100 dagen, om 12:11 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 inhalatie, inhalatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 dosis |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.125: | Regel 1.123: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_1_MA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 60 dagen, om 13:54 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Stoptype |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Indicatie vervallen (code = '9' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59, 1 maal per dag 1 dosis, inhalatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 dosis |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_1 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.164: | Regel 1.167: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_2_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 500 dagen, om 10:19 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 500 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 500 dagen, tot nader order, 1x per dag 1 druppel, in beide ogen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|In beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 | + | |style="background-color: white;"|1 maal per dag 1 druppel |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.208: | Regel 1.211: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_2_MA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 366 dagen, om 17:54 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Stoptype | ||
+ | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Indicatie vervallen (code = '9' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00, 1x per dag 1 druppel, in beide ogen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|In beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 | + | |style="background-color: white;"|1 maal per dag 1 druppel |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.252: | Regel 1.258: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_3_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 100 dagen, om 12:11 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.271: | Regel 1.280: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_3 |
− | |} | + | |} |
− | + | {| class="wikitable" width="85%" | |
− | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | |
− | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.301: | Regel 1.299: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_3_MA_2 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 4 dagen, om 13:54 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Stoptype |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_3 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.329: | Regel 1.340: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_4_MA_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 300 dagen, om 14:23 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|Vanaf T- 300 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 300 dagen, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_4 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.368: | Regel 1.381: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_4_MA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 222 dagen, om 08:54 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Stoptype |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.390: | Regel 1.403: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_4 |
− | |} | + | |}<section end=MA_XXX_Cnossen /> |
+ | ===Toedieningsafspraken XXX_Cnossen === | ||
+ | <section begin=TA_XXX_Cnossen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.415: | Regel 1.424: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_1_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 100 dagen, om 12:11 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SPIRIVA INHALPDR 18MCG (code = '1476866' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.437: | Regel 1.443: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 inhalatie, inhalatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 | + | |style="background-color: white;"|1 maal per dag 1 dosis |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | + | |style="background-color: white;"|MBH_313_1_MA_1 | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.465: | Regel 1.465: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_1_TA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 60 dagen, om 13:54 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Stoptype |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SPIRIVA INHALPDR 18MCG (code = '1476866' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.484: | Regel 1.487: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot | + | |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59, 1 maal per dag 1 dosis, inhalatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 | + | |style="background-color: white;"|1 maal per dag 1 dosis |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | + | |style="background-color: white;"|MBH_313_1_MA_2 | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.512: | Regel 1.509: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_2_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 500 dagen, om 10:19 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 500 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 500 dagen, tot nader order, 1x per dag 1 druppel, in beide ogen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|In beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 | + | |style="background-color: white;"|1 maal per dag 1 druppel |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_2_MA_1 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.556: | Regel 1.553: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_2_TA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 366 dagen, om 17:54 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Stoptype |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00, 1x per dag 1 druppel, in beide ogen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|In beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 1 druppel |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | + | |style="background-color: white;"|MBH_313_2_MA_2 | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.603: | Regel 1.600: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_3_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 100 dagen, om 12:30 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.625: | Regel 1.619: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | + | |style="background-color: white;"|MBH_313_3_MA_1 | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_3 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.651: | Regel 1.640: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_3_TA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T- 4 dagen, om 14:54 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Stoptype |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | === | + | |colspan="3"|Geneesmiddel |
− | + | |style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534' in codeSystem 'G-Standaard HPK') | |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_313_3_MA_2 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_313_3 | ||
+ | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.676: | Regel 1.685: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_4_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 300 dagen, om 15:23 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 300 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.701: | Regel 1.704: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 300 dagen, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_313_4_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_4 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.720: | Regel 1.726: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_4_TA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om 09: | + | |style="background-color: white;"|T- 222 dagen, om 09:54 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Stoptype |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.742: | Regel 1.748: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_313_4_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_4 |
− | |} | + | |}<section end=TA_XXX_Cnossen /> |
+ | ===Medicatiegebruik XXX_Cnossen === | ||
+ | <section begin=MGB_XXX_Cnossen /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.761: | Regel 1.772: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_1_MGB_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2018-07-06T12:11:00 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 2018-07-06T00:00:00, tot nader order |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.786: | Regel 1.794: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 | + | |style="background-color: white;"|Vanaf 2018-07-06T00:00:00, tot nader order, Vanaf T-100, tot nader order, 1 maal per dag 1 inhalatie, inhalatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 | + | |style="background-color: white;"|1 maal per dag 1 dosis |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_313_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.808: | Regel 1.819: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_1_MGB_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2018-06-18T15:25:00 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|False | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot en met 2018-06-18T23:59:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Stoptype |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.836: | Regel 1.844: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot en met 2018-06-18T23:59:00, Vanaf T-100, tot en met T-59, 1 maal per dag 1 dosis, inhalatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 1 dosis |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_313_1_MA_2 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.855: | Regel 1.869: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_2_MGB_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|2017-04-03T10:19:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|True |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 2017-04-03T00:00:00, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf 2017-04-03T00:00:00, tot nader order, Vanaf T-500, tot nader order, 1x per dag 1 druppel, in beide ogen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|In beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 druppel |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_2_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_2 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.910: | Regel 1.919: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_2_MGB_2 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|2017-08-15T17:54:00 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|True |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 2017-04-03T00:00:00, tot en met 2017-08-15T17:00:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Stoptype |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf 2017-04-03T00:00:00, tot en met 2017-08-15T17:00:00, Vanaf T-500, tot en met T-366 17:00, 1x per dag 1 druppel, in beide ogen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|In beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 | + | |style="background-color: white;"|1 maal per dag 1 druppel |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_313_2_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.954: | Regel 1.972: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_3_MGB_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2018-05-08T12:11:00 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 1.976: | Regel 1.994: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot nader order, Vanaf T-100, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_3_MA_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_3 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 1.998: | Regel 2.019: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_3_MGB_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2017-08-12T13:54:00 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot en met 2018-08-11T23:59:00 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Stoptype | ||
+ | |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.017: | Regel 2.044: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- 5 | + | |style="background-color: white;"|Vanaf 2018-05-08T00:00:00, tot en met 2018-08-11T23:59:00, Vanaf T-100, tot en met T-5, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-4 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_3_MA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_3 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
Regel 2.047: | Regel 2.069: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_4_MGB_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2017-10-20T14:23:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|True |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 2017-10-20T00:00:00, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.069: | Regel 2.091: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf 2017-10-20T00:00:00, tot nader order, Vanaf T-300, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
Regel 2.078: | Regel 2.100: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gerelateerde afspraak : MA | |colspan="3"|Gerelateerde afspraak : MA | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_4_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_4 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 2.094: | Regel 2.116: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_4_MGB_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Registratiedatum | |colspan="3"|Registratiedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2018-01-06T08:54:00 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruik indicator | |colspan="3"|Gebruik indicator | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|True |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 2017-10-20T00:00:00, tot en met 2018-01-05T23:59:00 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Stoptype | ||
+ | |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.116: | Regel 2.141: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf 2017-10-20T00:00:00, tot en met 2018-01-05T23:59:00, Vanaf T-300, tot en met T-223, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-222 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
Regel 2.125: | Regel 2.150: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gerelateerde afspraak : MA | |colspan="3"|Gerelateerde afspraak : MA | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_4_MA_2 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_313_4 |
− | |} | + | |}<section end=MGB_XXX_Cnossen /> |
+ | ==Patiënt R. XXX_Dirksz== | ||
+ | <section begin=XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.143: | Regel 2.167: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|R. XXX_Dirksz |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Patient identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|999911326 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Patient identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|11101 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 aug 1964 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Geneesmiddel | + | |colspan="3"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |}<section end=XXX_Dirksz /> |
+ | ===Medicatieafspraken XXX_Dirksz === | ||
+ | <section begin=MA_XXX_Dirksz /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_113_1_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 50 dagen, om 11:25 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 30 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
Regel 2.163: | Regel 2.214: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 stuk | + | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.191: | Regel 2.233: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_2_MA_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 30 dagen, om 14:55 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"|T, | + | |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.210: | Regel 2.255: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.235: | Regel 2.274: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_3_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 30 dagen, om 14:57 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 30 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 30 dagen, tot nader order, 1 maal per dag 1 stuk, oraal |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 1 stuk |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_3 |
− | |} | + | |}<section end=MA_XXX_Dirksz /> |
+ | ===Verstrekkingsverzoeken XXX_Dirksz === | ||
+ | <section begin=VV_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.282: | Regel 2.317: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_1_VV_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 50 dagen, om 11:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Beoogd verstrekker |
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Relatie naar medicatieafspraak | |
− | + | |style="background-color: white;"|MBH_113_1_MA_1 | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"| | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_1 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.330: | Regel 2.347: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_2_VV_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T- 30 dagen, om 14:55 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|21 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | === | + | |colspan="3"|Beoogd verstrekker |
− | + | |style="background-color: white;"|Apotheek De Gulle Gaper | |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_113_2_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_113_2 | ||
+ | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.355: | Regel 2.379: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_3_VV_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 30 dagen, om 14:57 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|21 stuks |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Beoogd verstrekker |
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_3_MA_1 |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_3 |
− | |} | + | |}<section end=VV_XXX_Dirksz /> |
+ | ===Toedieningsafspraken XXX_Dirksz === | ||
+ | <section begin=TA_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.399: | Regel 2.412: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_1_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 50 dagen, om 11:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PRIMPERAN ZETPIL 20MG (code = '229709' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.421: | Regel 2.431: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 stuk | + | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_113_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.440: | Regel 2.453: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_2_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om 14: | + | |style="background-color: white;"|T- 30 dagen, om 14:55 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.465: | Regel 2.472: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_2_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.487: | Regel 2.494: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_3_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om 14: | + | |style="background-color: white;"|T- 30 dagen, om 14:57 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 30 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | + | |style="background-color: white;"|Apotheek De Gulle Gaper | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.515: | Regel 2.513: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 30 dagen, tot nader order, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_113_2_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_3 |
− | |} | + | |}<section end=TA_XXX_Dirksz /> |
+ | ===Verstrekkingen XXX_Dirksz === | ||
+ | <section begin=MVE_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.534: | Regel 2.537: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_1_MVE_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 50 dagen, om 12:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|PRIMPERAN ZETPIL 20MG (code = '229709' in codeSystem 'G-Standaard HPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Relatie naar verstrekkingsverzoek |
+ | |style="background-color: white;"|MBH_113_1_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_1 |
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_2_MVE_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Datum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T- 30 dagen, om 15:55 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|25 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zestril tablet 10mg (code = '615560' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar verstrekkingsverzoek |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_2_VV_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_2 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.589: | Regel 2.593: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_3_MVE_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Datum | |colspan="3"|Datum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|T- 30 dagen, om 15:56 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|21 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Relatie naar verstrekkingsverzoek | |
− | + | |style="background-color: white;"|MBH_113_3_VV_1 | |
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"|Relatie naar | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_3 |
− | |} | + | |}<section end=MVE_XXX_Dirksz /> |
+ | ===Medicatiegebruik XXX_Dirksz === | ||
+ | <section begin=MGB_XXX_Dirksz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.623: | Regel 2.623: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_1_MGB_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T- 48 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|True |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 48 dagen, gedurende 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 48 dagen, gedurende 1 dag, zo nodig 1 maal per dag 1 stuk, rectaal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_1_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_1 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.662: | Regel 2.670: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_2_MGB_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T- 13 dagen, om 14:55 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Volgens afspraak indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|True |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.684: | Regel 2.695: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_2_MA_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.706: | Regel 2.720: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_3_MGB_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 29 dagen, om 14:57 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 29 dagen, tot en met T- 8 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.728: | Regel 2.742: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 29 dagen, tot en met T- 8 dagen, om 23:59, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_3_MA_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_113_3 |
− | |} | + | |}<section end=MGB_XXX_Dirksz /> |
+ | ==Patiënt R. XXX_Gobee== | ||
+ | <section begin=XXX_Gobee /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|R. XXX_Gobee | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Patient identificatienummer | ||
+ | |style="background-color: white;"|999911314 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Patient identificatienummer | ||
+ | |style="background-color: white;"|21104 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geboortedatum | ||
+ | |style="background-color: white;"|1 aug 1964 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geslacht | ||
+ | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') | ||
+ | |}<section end=XXX_Gobee /> | ||
+ | ===Medicatieafspraken XXX_Gobee === | ||
+ | <section begin=MA_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.750: | Regel 2.793: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 50 dagen, om 11:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 50 dagen, tot nader order |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.769: | Regel 2.815: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 50 dagen, tot nader order, 1 à 2 maal per dag 1 tablet, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 2.775: | Regel 2.821: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 à 2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|MBH identificatie | |
− | + | |style="background-color: white;"|MBH_213_1 | |
− | + | |} | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | ||
− | |} | ||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.799: | Regel 2.834: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 40 dagen, om 09:13 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Stoptype | ||
+ | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar afspraak of gebruik: MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59, 1 à 2 maal per dag 1 tablet, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 à 2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.827: | Regel 2.878: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MA_3 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 40 dagen, om 09:13 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 30 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar afspraak of gebruik: MA | ||
+ | |style="background-color: white;"|MBH_213_1_MA_2 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Geen of onvoldoende effect (code = '5' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.866: | Regel 2.922: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MA_4 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 15 dagen, om 09:13 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Stoptype |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar afspraak of gebruik: MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MA_3 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.888: | Regel 2.947: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59, 2 maal per dag 1 tablet, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 2.894: | Regel 2.953: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.913: | Regel 2.966: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MA_5 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 15 dagen, om 16:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar afspraak of gebruik: MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MA_4 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Wens patiënt (code = '12' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 2.935: | Regel 2.991: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 2.942: | Regel 2.998: | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
− | |} | + | |}<section end=MA_XXX_Gobee /> |
+ | ===Verstrekkingsverzoeken XXX_Gobee === | ||
+ | <section begin=VV_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 2.963: | Regel 3.012: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_VV_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 50 dagen, om 11:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|40 stuks |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Aantal herhalingen | ||
+ | |style="background-color: white;"|1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Beoogd verstrekker |
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Relatie naar medicatieafspraak | |
− | + | |style="background-color: white;"|MBH_213_1_MA_1 | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"| | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.010: | Regel 3.046: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_VV_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 40 dagen, om 09:13 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|60 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Aantal herhalingen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Beoogd verstrekker |
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MA_3 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_VV_3 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T- 15 dagen, om 16:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verbruiksperiode | ||
+ | |style="background-color: white;"|Tot nader order | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Beoogd verstrekker | ||
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_213_1_MA_5 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
− | |} | + | |}<section end=VV_XXX_Gobee /> |
+ | ===Toedieningsafspraken XXX_Gobee === | ||
+ | <section begin=TA_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.054: | Regel 3.113: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 50 dagen, om 11:25 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 50 dagen, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 50 dagen, tot nader order, 1 à 2 maal per dag 1 tablet, oraal |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 à 2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | + | |style="background-color: white;"|MBH_213_1_MA_1 | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.101: | Regel 3.154: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_TA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 40 dagen, om 09:13 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Stoptype |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.123: | Regel 3.176: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59, 1 à 2 maal per dag 1 tablet, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.129: | Regel 3.182: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 stuk | + | |style="background-color: white;"|1 à 2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | + | |style="background-color: white;"|MBH_213_1_MA_2 | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.174: | Regel 3.198: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_TA_3 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 40 dagen, om 09:13 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.199: | Regel 3.217: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.205: | Regel 3.223: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_213_1_MA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.218: | Regel 3.239: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_TA_4 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om 09: | + | |style="background-color: white;"|T- 15 dagen, om 09:13 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Stoptype |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.240: | Regel 3.261: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59, 2 maal per dag 1 tablet, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.246: | Regel 3.267: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_213_1_MA_4 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.259: | Regel 3.283: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_TA_5 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 15 dagen, om 16:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.284: | Regel 3.302: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.292: | Regel 3.310: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MA_5 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
− | |} | + | |}<section end=TA_XXX_Gobee /> |
+ | ===Verstrekkingen XXX_Gobee === | ||
+ | <section begin=MVE_XXX_Gobee /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.306: | Regel 3.326: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MVE_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 50 dagen, om 13:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|40 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_213_1_VV_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MVE_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T- 40 dagen, om 09:13 |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Verstrekker |
+ | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Verstrekte hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|60 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar verstrekkingsverzoek |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_VV_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.353: | Regel 3.382: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MVE_3 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 15 dagen, om 17:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Gebruiksperiode | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Apotheek de Gulle Gaper |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|30 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verbruiksduur | ||
+ | |style="background-color: white;"|30 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_213_1_VV_2 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_213_1 | ||
+ | |}<section end=MVE_XXX_Gobee /> | ||
+ | ===Medicatiegebruik XXX_Gobee === | ||
+ | <section begin=MGB_XXX_Gobee /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_213_1_MGB_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T- 47 dagen, om 11:25 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 3 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.375: | Regel 3.437: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 3 dagen, 1 maal per dag 1 tablet, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.381: | Regel 3.443: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|MBH identificatie | |
− | + | |style="background-color: white;"|MBH_213_1 | |
− | + | |} | |
− | |||
− | |||
− | |||
− | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | ||
− | |} | ||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.408: | Regel 3.462: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MGB_2 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T- 41 dagen, om 11:25 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|True |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 46 dagen, gedurende 6 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 46 dagen, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.442: | Regel 3.509: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MGB_3 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 35 dagen, om 19:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruik indicator |
− | |style="background-color: white;"| | + | |style="background-color: white;"|True |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"|40 | + | |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 6 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gerelateerde afspraak : TA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_TA_3 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.481: | Regel 3.553: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MGB_4 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 16 dagen, om 11:25 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T- 34 dagen, gedurende 19 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.503: | Regel 3.575: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T- 34 dagen, gedurende 19 dagen, 2 maal per dag 1 tablet, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.509: | Regel 3.581: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_213_1_MA_3 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.525: | Regel 3.600: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MGB_5 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 10 dagen, om 11:25 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.547: | Regel 3.622: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 5 dagen, 1 maal per dag 1 tablet, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.555: | Regel 3.630: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gerelateerde afspraak : MA |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1_MA_5 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_213_1 |
− | |} | + | |}<section end=MGB_XXX_Gobee /> |
+ | ==Patiënt J. XXX_Kilkenny== | ||
+ | <section begin=XXX_Kilkenny /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patiënt |
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|J. XXX_Kilkenny | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Patient identificatienummer | ||
+ | |style="background-color: white;"|999911752 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Patient identificatienummer | ||
+ | |style="background-color: white;"|22108 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geboortedatum | ||
+ | |style="background-color: white;"|5 aug 1964 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geslacht | ||
+ | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') | ||
+ | |}<section end=XXX_Kilkenny /> | ||
+ | ===Medicatieafspraken XXX_Kilkenny === | ||
+ | <section begin=MA_XXX_Kilkenny /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.569: | Regel 3.673: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_323_1_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T- 5 dagen, om | + | |style="background-color: white;"|T- 5 dagen, om 15:34 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 20 dagen, tot en met T- 6 dagen, om 23:59 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Stoptype | ||
+ | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.588: | Regel 3.695: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 20 dagen, tot en met T- 6 dagen, om 23:59, 3x per dag 1 tablet |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|3 maal per dag 1 stuk | |style="background-color: white;"|3 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_323_1 |
+ | |}<section end=MA_XXX_Kilkenny /> | ||
+ | ===Medicatiegebruik XXX_Kilkenny === | ||
+ | <section begin=MGB_XXX_Kilkenny /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_323_1_MGB_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Registratiedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T- 10 dagen, om 11:25 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 20 dagen, tot nader order |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 20 dagen, tot nader order, 3x per dag 1 tablet |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_323_1 |
− | |} | + | |}<section end=MGB_XXX_Kilkenny /> |
+ | ==Patiënt R. XXX_Ruys== | ||
+ | <section begin=XXX_Ruys /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.645: | Regel 3.758: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|R. XXX_Ruys |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Patient identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|999911351 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Patient identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|13103 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 aug 1964 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
+ | |}<section end=XXX_Ruys /> | ||
+ | ==Patiënt R. XXX_Strengersz== | ||
+ | <section begin=XXX_Strengersz /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patiënt | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|R. XXX_Strengersz |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Patient identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|999911338 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Patient identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|41106 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geboortedatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 aug 1964 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geslacht |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') |
− | |}<section end= | + | |}<section end=XXX_Strengersz /> |
− | === | + | ===Medicatieafspraken XXX_Strengersz === |
− | <section begin= | + | <section begin=MA_XXX_Strengersz /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.685: | Regel 3.807: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_1_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 11:25 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.707: | Regel 3.829: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.713: | Regel 3.835: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 stuk | + | |style="background-color: white;"|1 à 2 maal per dag 1 stuk |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.732: | Regel 3.848: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_2_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T, om 11:25 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-StandaardGPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.754: | Regel 3.870: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.782: | Regel 3.889: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_3_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 50 dagen, om 11:25 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 3.801: | Regel 3.911: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 3.807: | Regel 3.917: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 à 2 stuks |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_3 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.829: | Regel 3.930: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_4_MA_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Afspraakdatum | ||
+ | |style="background-color: white;"|T- 20 dagen, om 10:26 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"|T, | + | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-StandaardGPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_4 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.873: | Regel 3.974: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_5_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 20 dagen, om 10:46 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ibuprofen PCH tablet 600mg (code = '641898' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 0.25 stuk |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_5 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 3.920: | Regel 4.015: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_6_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, gedurende 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Waterstofperoxide 30MG/ML (code = '67016' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Niet van toepassing (code = '1' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 10 à 15 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_6 |
− | |} | + | |} |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | ||
Regel 3.993: | Regel 4.062: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_7_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 14 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 4.011: | Regel 4.077: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.018: | Regel 4.084: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_7 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 4.037: | Regel 4.103: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_8_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om 09: | + | |style="background-color: white;"|T, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T, gedurende 10 weken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 4.052: | Regel 4.118: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Op maandag, woensdag en vrijdag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_8 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 4.078: | Regel 4.150: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_9_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
|style="background-color: white;"|Vanaf T, tot nader order | |style="background-color: white;"|Vanaf T, tot nader order | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.103: | Regel 4.172: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal | + | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 4.109: | Regel 4.178: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 stuk | + | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_9 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 4.125: | Regel 4.191: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_10_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, tot nader order |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 4.159: | Regel 4.219: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Herhaalperiode cyclisch schema | ||
+ | |style="background-color: white;"|28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_10 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 4.172: | Regel 4.235: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_11_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 41 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Reden afspraak | |colspan="3"|Reden afspraak | ||
Regel 4.187: | Regel 4.250: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Dun aanbrengen (code = '1033' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"|Doseerinstructie | + | |colspan="2"|Doseerinstructie 1 |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie 2 |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie 3 |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_11 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.227: | Regel 4.285: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_12_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 11:25 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 3 weken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.249: | Regel 4.307: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 4.255: | Regel 4.313: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_12 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.274: | Regel 4.326: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_13_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 28 dagen, om 09:12 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 28 dagen, gedurende 8 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden afspraak | ||
+ | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.296: | Regel 4.348: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 28 dagen, gedurende 8 dagen, 0.5 ml per uur parenteraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|0.5 ml per uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_13 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.324: | Regel 4.367: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_13_MA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 20 dagen, om 11:25 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 8 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.343: | Regel 4.389: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot | + | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|0.2 à 0.5 ml per uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_13 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.371: | Regel 4.408: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_14_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T, om 11:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Voorschrijver |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.390: | Regel 4.427: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 stuk | + | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_14 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.415: | Regel 4.446: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_15_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 09:35 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 4 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Voorschrijver | |colspan="3"|Voorschrijver | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Reden afspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Geneesmiddel - Product specificatie |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="16"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Product naam |
+ | |style="background-color: white;"|Haparine 100 ie= 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Farmaceutische vorm | ||
+ | |style="background-color: white;"|Vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Sterkte |
− | |style="background-color: | + | |style="background-color: white;"|100 internationale eenheid per 10 ml |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Sterkte |
− | |style="background-color: | + | |style="background-color: white;"|1 stuk per 10 ml |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Sterkte |
− | |style="background-color: white;"| | + | |style="background-color: white;"|0.09 gram per 10 ml |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.484: | Regel 4.508: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 10 ml |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_15 |
− | |}<section end= | + | |}<section end=MA_XXX_Strengersz /> |
− | == | + | ===Verstrekkingsverzoeken XXX_Strengersz === |
− | <section begin= | + | <section begin=VV_XXX_Strengersz /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.510: | Regel 4.528: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_15_VV_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Datum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Auteur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"| | + | |style="background-color: white;"|100 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Aantal herhalingen |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 |
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | + | |colspan="4"|Geneesmiddel - Product specificatie | |
− | |||
− | |||
− | |style=" | ||
− | |||
− | |colspan=" | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="16"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Product naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Haparine 100 ie= 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Farmaceutische vorm |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Sterkte |
− | |style="background-color: | + | |style="background-color: white;"|100 internationale eenheid per 10 ml |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Sterkte |
− | |style="background-color: | + | |style="background-color: white;"|1 stuk per 10 ml |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Sterkte |
+ | |style="background-color: white;"|0.09 gram per 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Beoogd verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_15_MA_1 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_15 |
− | |} | + | |}<section end=VV_XXX_Strengersz /> |
+ | ===Toedieningsafspraken XXX_Strengersz === | ||
+ | <section begin=TA_XXX_Strengersz /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.603: | Regel 4.605: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_1_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T, om 11:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
|style="background-color: white;"|Vanaf T, gedurende 60 dagen | |style="background-color: white;"|Vanaf T, gedurende 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-StandaardGPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.625: | Regel 4.624: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 4.631: | Regel 4.630: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 stuk | + | |style="background-color: white;"|1 à 2 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_413_1_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_1 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.644: | Regel 4.646: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_2_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T, om 11:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Geneesmiddel | |
− | + | |style="background-color: white;"|HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471' in codeSystem 'G-StandaardGPK') | |
− | |||
− | |||
− | |||
− | |||
− | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.669: | Regel 4.665: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_2_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_2 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.691: | Regel 4.687: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_3_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 50 dagen, om 11:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | + | |style="background-color: white;"|Apotheek De Gulle Gaper | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-StandaardGPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.719: | Regel 4.706: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 4.725: | Regel 4.712: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 à 2 stuks |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_413_3_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_3 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.738: | Regel 4.728: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_4_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T- | + | |style="background-color: white;"|T- 20 dagen, om 10:26 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Geneesmiddel | |
− | + | |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-StandaardGPK') | |
− | |||
− | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|3 maal per dag | + | |style="background-color: white;"|3 maal per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_4_MA_1 |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_4 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.793: | Regel 4.772: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_5_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T- 20 dagen, om 10:46 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ibuprofen PCH tablet 600mg (code = '641898' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|2 maal per dag 0.25 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie naar medicatieafspraak | |colspan="3"|Relatie naar medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_5_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_5 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 4.827: | Regel 4.813: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_6_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, gedurende 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|SOLUTIO HYDROGENII PEROXIDI 3% M/V (code = '603694' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Niet van toepassing (code = '1' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 10 à 15 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie naar medicatieafspraak | |colspan="3"|Relatie naar medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_6_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_6 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | ||
Regel 4.866: | Regel 4.860: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_7_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T, gedurende 14 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekker | |colspan="3"|Verstrekker | ||
Regel 4.881: | Regel 4.872: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.888: | Regel 4.879: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie naar medicatieafspraak | |colspan="3"|Relatie naar medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_7_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_7 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 4.910: | Regel 4.901: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_8_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 10 weken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekker | |colspan="3"|Verstrekker | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Op maandag, woensdag en vrijdag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie naar medicatieafspraak | |colspan="3"|Relatie naar medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_8_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_8 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
Regel 4.954: | Regel 4.948: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_9_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Afspraakdatum | |colspan="3"|Afspraakdatum | ||
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 09:35 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekker | |colspan="3"|Verstrekker | ||
Regel 4.966: | Regel 4.960: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 4.973: | Regel 4.967: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 4.979: | Regel 4.973: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Relatie naar medicatieafspraak | |colspan="3"|Relatie naar medicatieafspraak | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_9_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_9 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 5.003: | Regel 4.989: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_10_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T, om 09:35 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, tot nader order | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekker | |colspan="3"|Verstrekker | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="5"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Herhaalperiode cyclisch schema |
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Relatie naar | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_10_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_10 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 5.031: | Regel 5.033: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_11_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 09:35 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 41 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verstrekker | |colspan="3"|Verstrekker | ||
− | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUCIDIN CREME 20MG/G (code = '420956' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"|Relatie naar | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Dun aanbrengen (code = '1033' in codeSystem 'NHG tabel 25 aanvullende teksten') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie 1 | ||
+ | |style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie 2 | ||
+ | |style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie 3 | ||
+ | |style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_413_11_MA_1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_11 |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 5.070: | Regel 5.083: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_12_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T, om 11:25 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 3 weken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 5.092: | Regel 5.102: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
Regel 5.098: | Regel 5.108: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | + | |style="background-color: white;"|MBH_413_12_MA_1 | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_12 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 5.117: | Regel 5.124: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_13_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 28 dagen, om 09:12 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 28 dagen, gedurende 8 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 5.139: | Regel 5.143: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T- | + | |style="background-color: white;"|Vanaf T- 28 dagen, gedurende 8 dagen, 0.5 ml per uur parenteraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|0.5 ml per uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | + | |style="background-color: white;"|MBH_413_13_MA_1 | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_13 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 5.167: | Regel 5.165: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_13_TA_2 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T- 20 dagen, om 11:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 8 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 5.186: | Regel 5.184: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T, tot | + | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|0.2 à 0.5 ml per uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | + | |style="background-color: white;"|MBH_413_13_MA_2 | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_13 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 5.214: | Regel 5.206: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_14_TA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Afspraakdatum |
− | |style="background-color: white;"|T, om | + | |style="background-color: white;"|T, om 11:25 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf 2018-08-16T00:00:00, tot nader order |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Verstrekker |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 5.233: | Regel 5.225: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf | + | |style="background-color: white;"|Vanaf 2018-08-16T00:00:00, tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"|1 maal per dag 1 stuk | + | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_14_MA_1 |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_14 |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
Regel 5.258: | Regel 5.247: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_15_TA_1 |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Afspraakdatum | ||
+ | |style="background-color: white;"|T, om 09:35 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: white;"|T- 3 | + | |style="background-color: white;"|Vanaf T, gedurende 4 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verstrekker | ||
+ | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="16"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Product naam | ||
+ | |style="background-color: white;"|Haparine 100 ie= 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Farmaceutische vorm | ||
+ | |style="background-color: white;"|Vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|100 internationale eenheid per 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|1 stuk per 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Sterkte |
− | |style="background-color: | + | |style="background-color: white;"|0.09 gram per 10 ml |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|2 maal per dag 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar medicatieafspraak | ||
+ | |style="background-color: white;"|MBH_413_15_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_15 | ||
+ | |}<section end=TA_XXX_Strengersz /> | ||
+ | ===Verstrekkingen XXX_Strengersz === | ||
+ | <section begin=MVE_XXX_Strengersz /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_9_MVE_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Datum | ||
+ | |style="background-color: white;"|T, om 10:35 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verstrekker | ||
+ | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|90 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel | |colspan="3"|Geneesmiddel | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Distributievorm | ||
+ | |style="background-color: white;"|Geïndividualiseerd distributiesysteem (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_9 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekking | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_15_MVE_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Datum | ||
+ | |style="background-color: white;"|T, om 10:35 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verstrekker | ||
+ | |style="background-color: white;"|Apotheek de Gulle Gaper | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Verstrekte hoeveelheid | ||
+ | |style="background-color: white;"|100 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="16"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Product naam | ||
+ | |style="background-color: white;"|Haparine 100 ie= 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Farmaceutische vorm | ||
+ | |style="background-color: white;"|Vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|100 internationale eenheid per 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|1 stuk per 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|0.09 gram per 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Relatie naar verstrekkingsverzoek | ||
+ | |style="background-color: white;"|MBH_513_15_VV_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_15 | ||
+ | |}<section end=MVE_XXX_Strengersz /> | ||
+ | ===Medicatiegebruik XXX_Strengersz === | ||
+ | <section begin=MGB_XXX_Strengersz /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_1_MGB_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 16:25 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 60 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_413_1_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_1 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_2_MGB_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 14:25 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 14 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-StandaardGPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 14 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|Exact iedere 3 uur 16 internationale eenheid | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_413_2_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_2 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_3_MGB_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 10:45 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|3 maal per dag 1 à 2 stuks | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_413_3_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_3 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_4_MGB_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T- 15 dagen, om 13:44 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 20 dagen, tot en met T- 15 dagen, om 23:59 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-StandaardGPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="5"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 20 dagen, tot en met T- 15 dagen, om 23:59, 3 maal per dag aanbrengen, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|3 maal per dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_413_4_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_4 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_5_MGB_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 12:38 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|Ibuprofen PCH tablet 600mg (code = '641898' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T- 20 dagen, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|2 maal per dag 0.25 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_413_5_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_5 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_6_MGB_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 21:37 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 1 dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|Waterstofperoxide 30MG/ML (code = '67016' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 1 dag, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Niet van toepassing (code = '1' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|2 maal per dag 10 à 15 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_413_6_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_6 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_7_MGB_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 14:05 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, om 14:00, tot en met T, om 14:05 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, om 14:00, tot en met T, om 14:05, om 14:00 16IE | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|Elke dag om 16 internationale eenheid | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_413_7_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_7 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_7_MGB_2 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 20:10 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, om 20:00, tot en met T, om 20:05 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, om 20:00, tot en met T, om 20:05, om 20:00 16IE | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|Elke dag om 16 internationale eenheid | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_413_7_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_7 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_8_MGB_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 23:59 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 10 weken | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="5"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|Op maandag, woensdag en vrijdag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_413_8_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_8 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_9_MGB_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 22:35 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, tot nader order | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_413_9_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_9 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_10_MGB_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 09:35 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, tot nader order | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|Gedurende 21 dagen 1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Herhaalperiode cyclisch schema | ||
+ | |style="background-color: white;"|28 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_413_10_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_10 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_11_MGB_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 15:35 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 41 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|Dun aanbrengen (code = '1033' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie 1 | ||
+ | |style="background-color: white;"|Eerst gedurende 2 weken 1 maal per dag 3 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|Dan gedurende 3 weken 1 maal per dag 2 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|Dan gedurende 6 dagen 1 maal per dag 1 gram | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_413_11_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_11 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_12_MGB_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 22:35 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 3 weken | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|Bij hoest 3 à 4 maal per uur 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_413_12_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_12 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_14_MGB_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 22:35 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel | ||
+ | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gerelateerde afspraak : MA | ||
+ | |style="background-color: white;"|MBH_413_14_MA_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Auteur | ||
+ | |style="background-color: white;"|Patiënt | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_413_14 | ||
+ | |} | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_413_15_MGB_1 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Registratiedatum | ||
+ | |style="background-color: white;"|T, om 10:35 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruik indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Volgens afspraak indicator | ||
+ | |style="background-color: white;"|True | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: white;"|Vanaf T, gedurende 4 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Voorschrijver | ||
+ | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geneesmiddel - Product specificatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="16"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Product naam | ||
+ | |style="background-color: white;"|Haparine 100 ie= 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Farmaceutische vorm | ||
+ | |style="background-color: white;"|Vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|100 internationale eenheid per 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Ingredient | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Ingredient code | ||
+ | |style="background-color: white;"|WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | ||Sterkte | ||
+ | |style="background-color: white;"|1 stuk per 10 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | ||Sterkte |
− | + | |style="background-color: white;"|0.09 gram per 10 ml | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | | | ||
− | | | ||
− | | | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
Regel 5.327: | Regel 6.190: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 10 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gerelateerde afspraak : MA | |colspan="3"|Gerelateerde afspraak : MA | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_15_MA_1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Auteur | |colspan="3"|Auteur | ||
Regel 5.342: | Regel 6.205: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_413_15 |
|}<section end=MGB_XXX_Strengersz /> | |}<section end=MGB_XXX_Strengersz /> |
Versie van 8 okt 2018 14:13
Deze pagina is nog in bewerking |
Addenda voor inhoudelijke gegevens
Patiënt J. XXX_Amaya
Patiënt | |||
Gegevenselement | Waarde | ||
Naamgegevens | J. XXX_Amaya | ||
Patient identificatienummer | 999911764 [BSN] | ||
Patient identificatienummer | 51107 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 6 aug 1964 | ||
Geslacht | Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Amaya
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_1 | ||
Afspraakdatum | T- 1 dag, om 11:25 | ||
Gebruiksperiode | Vanaf T- 1 dag, gedurende 60 dagen | ||
Geannuleerd indicator | True | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 1 dag, gedurende 60 dagen, 10 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 10 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_MA_2 | ||
Afspraakdatum | T, om 09:00 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_513_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MA_2 | ||
Afspraakdatum | T, om 14:32 | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Relatie naar afspraak of gebruik: TA | MBH_513_2_TA_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Toelichting | Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1 | ||
MBH identificatie | MBH_513_2 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MA_1 | ||
Afspraakdatum | T, om 14:32 | ||
Gebruiksperiode | Vanaf T, gedurende 28 dagen | ||
Relatie naar afspraak of gebruik: MGB | MBH_513_3_MGB_1 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Reden afspraak | Opname (code = '305335007' in codeSystem 'SNOMED CT') | ||
Reden van voorschrijven | Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL') | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
MBH identificatie | MBH_513_3 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MA_1 | ||
Afspraakdatum | T- 5 dagen, om 09:35 | ||
Gebruiksperiode | Vanaf T- 5 dagen, gedurende 10 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Lichaamslengte | 155 | ||
Lichaamsgewicht | 54 | ||
Aanvullende informatie | Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
Toelichting | In overleg met specialist | ||
MBH identificatie | MBH_513_4 |
Verstrekkingsverzoeken XXX_Amaya
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_VV_2 | ||
Datum | 2018-08-16T14:32:00 | ||
Auteur | Hans van Doorn - Huisartsen, niet nader gespecificeerd. Ziekenhuis Stitswerd | ||
Te verstrekken hoeveelheid | 30 stuks | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Toelichting | Nog in te vullen, zie word... | ||
Relatie naar medicatieafspraak | MBH_513_2_MA_2 | ||
MBH identificatie | MBH_513_2 |
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_VV_1 | ||
Datum | T- 5 dagen, om 09:35 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 40 stuks | ||
Geneesmiddel | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Afleverlocatie | Huisadres patiënt | ||
Aanvullende wensen | Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051') | ||
Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||
MBH identificatie | MBH_513_4 |
Toedieningsafspraken XXX_Amaya
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_1_TA_1 | ||
Afspraakdatum | T, om 12:25 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Geannuleerd indicator | True | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_513_1_MA_2 | ||
MBH identificatie | MBH_513_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_TA_1 | ||
Afspraakdatum | T- 7 dagen, om 14:52 | ||
Gebruiksperiode | Vanaf T- 7 dagen, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Reden afspraak | Opname | ||
Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 7 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_513_2_MA_1 | ||
MBH identificatie | MBH_513_2 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_TA_1 | ||
Afspraakdatum | T- 5 dagen, om 09:45 | ||
Gebruiksperiode | Vanaf T- 5 dagen, gedurende 10 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Aanvullende informatie | Gebruiksinstructie gegeven (code = '10' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053') | ||
Toelichting | Wegens niet leverbaar zijn van Broxil | ||
Relatie naar medicatieafspraak | MBH_513_4_MA_1 | ||
MBH identificatie | MBH_513_4 |
Verstrekkingen XXX_Amaya
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MVE_1 | ||
Aanschrijfdatum | T, om 14:32 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK') | ||
Relatie naar verstrekkingsverzoek | MBH_513_2_VV_2 | ||
MBH identificatie | MBH_513_2 |
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MVE_1 | ||
Datum | T- 5 dagen, om 09:45 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK') | ||
Afleverlocatie | Huisadres patiënt | ||
Aanvullende informatie | Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | ||
Toelichting | Patiënt gaf aan nog wat op voorraad te hebben, wens patiënt om minder te verstrekken. | ||
Relatie naar verstrekkingsverzoek | MBH_513_4_VV_1 | ||
MBH identificatie | MBH_513_4 |
Medicatiegebruik XXX_Amaya
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_1 | ||
Registratiedatum | T- 2 dagen, om 15:39 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T- 2 dagen, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_2 | ||
Registratiedatum | T, om 20:40 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T- 1 dag, tot nader order | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Informant | Persoon: M. XXX_Amaya - Mantelzorger. | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_2_MGB_3 | ||
Registratiedatum | T, om 21:39 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Geneesmiddel | Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_2_MA_1 | ||
Informant | Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Auteur | Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
MBH identificatie | MBH_513_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_5132_2_MGB_2 | ||
Registratiedatum | 2018-08-16T20:59:00 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf 2018-08-16T00:00:00, gedurende 1 dag | ||
Geneesmiddel | TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 2018-08-16T00:00:00, gedurende 1 dag, Vanaf T, gedurende 1 dag, 1 maal daags 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde verstrekking | MBH_5132_2_MVE_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_5132_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_3_MGB_1 | ||
Registratiedatum | T- 3 dagen, om 20:59 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59 | ||
Voorschrijver | Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd | ||
Geneesmiddel | Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
Gerelateerde afspraak : MA | MBH_513_3_MA_1 | ||
Auteur | Patiënt | ||
Reden gebruik | Lymfekanker | ||
MBH identificatie | MBH_513_3 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_513_4_MGB_1 | ||
Registratiedatum | T- 4 dagen, om 22:35 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | False | ||
Gebruiksperiode | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59 | ||
Geneesmiddel | AMOXICILLINE CAPSULE 250MG (code = '20044' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_513_4_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_513_4 |
Patiënt Pauline P. XXX_Bourgonje
Patiënt | |||
Gegevenselement | Waarde | ||
Naamgegevens | Pauline P. XXX_Bourgonje | ||
Patient identificatienummer | 999911296 [BSN] | ||
Patient identificatienummer | 12102 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 1 aug 1964 | ||
Geslacht | Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Bourgonje
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_123_1_MA_1 | ||
Afspraakdatum | T- 7 dagen | ||
Gebruiksperiode | Vanaf T- 7 dagen, tot nader order | ||
Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-StandaardGPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 7 dagen, tot nader order, Zo nodig 2 maal daags aanbrengen, op de huid | ||
Toedieningsweg | Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Doseerinstructie | Zo nodig 2 maal per dag | ||
MBH identificatie | MBH_123_1 |
Verstrekkingsverzoeken XXX_Bourgonje
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_123_1_VV_1 | ||
Datum | T- 7 dagen | ||
Auteur | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||
Te verstrekken hoeveelheid | 100 gram | ||
Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-StandaardGPK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Relatie naar medicatieafspraak | MBH_123_1_MA_1 | ||
MBH identificatie | MBH_123_1 |
Toedieningsafspraken XXX_Bourgonje
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_123_1_TA_1 | ||
Afspraakdatum | T- 7 dagen | ||
Gebruiksperiode | Vanaf T- 7 dagen, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 7 dagen, tot nader order, Zo nodig 2 maal daags aanbrengen, op de huid | ||
Toedieningsweg | Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Doseerinstructie | Zo nodig 2 maal per dag | ||
Relatie naar medicatieafspraak | MBH_123_1_MA_1 | ||
MBH identificatie | MBH_123_1 |
Verstrekkingen XXX_Bourgonje
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_123_1_MVE_1 | ||
Datum | T- 7 dagen | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 100 gram | ||
Geneesmiddel | CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') | ||
Relatie naar verstrekkingsverzoek | MBH_123_1_VV_1 | ||
MBH identificatie | MBH_123_1 |
Medicatiegebruik XXX_Bourgonje
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_123_1_MGB_1 | ||
Registratiedatum | 2018-08-12T20:58:00 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf 2018-08-11T00:00:00, gedurende 2 dagen | ||
Voorschrijver | Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost | ||
Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-StandaardGPK') | ||
Gebruiksinstructie | |||
Aanvullende instructie | Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Doseerinstructie | 2 maal per dag | ||
Gerelateerde afspraak : MA | MBH_123_1_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_123_1 |
Patiënt J. XXX_Cnossen
Patiënt | |||
Gegevenselement | Waarde | ||
Naamgegevens | J. XXX_Cnossen | ||
Patient identificatienummer | 999911740 [BSN] | ||
Patient identificatienummer | 31105 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 4 aug 1964 | ||
Geslacht | Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Cnossen
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_1_MA_1 | ||
Afspraakdatum | T- 100 dagen, om 12:11 | ||
Gebruiksperiode | Vanaf T- 100 dagen, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
Toedieningsweg | Inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 dosis | ||
MBH identificatie | MBH_313_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_1_MA_2 | ||
Afspraakdatum | T- 60 dagen, om 13:54 | ||
Gebruiksperiode | Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59 | ||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Indicatie vervallen (code = '9' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | ||
Geneesmiddel | Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59, 1 maal per dag 1 dosis, inhalatie | ||
Toedieningsweg | Inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 dosis | ||
MBH identificatie | MBH_313_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_2_MA_1 | ||
Afspraakdatum | T- 500 dagen, om 10:19 | ||
Gebruiksperiode | Vanaf T- 500 dagen, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 500 dagen, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
Toedieningsweg | Oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | In beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||
Doseerinstructie | 1 maal per dag 1 druppel | ||
MBH identificatie | MBH_313_2 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_2_MA_2 | ||
Afspraakdatum | T- 366 dagen, om 17:54 | ||
Gebruiksperiode | Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00 | ||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Indicatie vervallen (code = '9' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | ||
Geneesmiddel | Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00, 1x per dag 1 druppel, in beide ogen | ||
Toedieningsweg | Oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | In beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||
Doseerinstructie | 1 maal per dag 1 druppel | ||
MBH identificatie | MBH_313_2 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_3_MA_1 | ||
Afspraakdatum | T- 100 dagen, om 12:11 | ||
Gebruiksperiode | Vanaf T- 100 dagen, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_313_3 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_3_MA_2 | ||
Afspraakdatum | T- 4 dagen, om 13:54 | ||
Gebruiksperiode | Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59 | ||
Stoptype | Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_313_3 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_4_MA_1 | ||
Afspraakdatum | T- 300 dagen, om 14:23 | ||
Gebruiksperiode | Vanaf T- 300 dagen, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 300 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_313_4 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_4_MA_2 | ||
Afspraakdatum | T- 222 dagen, om 08:54 | ||
Gebruiksperiode | Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59 | ||
Stoptype | Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_313_4 |
Toedieningsafspraken XXX_Cnossen
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_1_TA_1 | ||
Afspraakdatum | T- 100 dagen, om 12:11 | ||
Gebruiksperiode | Vanaf T- 100 dagen, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | SPIRIVA INHALPDR 18MCG (code = '1476866' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
Toedieningsweg | Inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 dosis | ||
Relatie naar medicatieafspraak | MBH_313_1_MA_1 | ||
MBH identificatie | MBH_313_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_1_TA_2 | ||
Afspraakdatum | T- 60 dagen, om 13:54 | ||
Gebruiksperiode | Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59 | ||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | SPIRIVA INHALPDR 18MCG (code = '1476866' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59, 1 maal per dag 1 dosis, inhalatie | ||
Toedieningsweg | Inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 dosis | ||
Relatie naar medicatieafspraak | MBH_313_1_MA_2 | ||
MBH identificatie | MBH_313_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_2_TA_1 | ||
Afspraakdatum | T- 500 dagen, om 10:19 | ||
Gebruiksperiode | Vanaf T- 500 dagen, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 500 dagen, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
Toedieningsweg | Oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | In beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||
Doseerinstructie | 1 maal per dag 1 druppel | ||
Relatie naar medicatieafspraak | MBH_313_2_MA_1 | ||
MBH identificatie | MBH_313_2 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_2_TA_2 | ||
Afspraakdatum | T- 366 dagen, om 17:54 | ||
Gebruiksperiode | Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00 | ||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00, 1x per dag 1 druppel, in beide ogen | ||
Toedieningsweg | Oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | In beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||
Doseerinstructie | 1 maal per dag 1 druppel | ||
Relatie naar medicatieafspraak | MBH_313_2_MA_2 | ||
MBH identificatie | MBH_313_2 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_3_TA_1 | ||
Afspraakdatum | T- 100 dagen, om 12:30 | ||
Gebruiksperiode | Vanaf T- 100 dagen, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_313_3_MA_1 | ||
MBH identificatie | MBH_313_3 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_3_TA_2 | ||
Afspraakdatum | T- 4 dagen, om 14:54 | ||
Gebruiksperiode | Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59 | ||
Stoptype | Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_313_3_MA_2 | ||
MBH identificatie | MBH_313_3 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_4_TA_1 | ||
Afspraakdatum | T- 300 dagen, om 15:23 | ||
Gebruiksperiode | Vanaf T- 300 dagen, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 300 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_313_4_MA_1 | ||
MBH identificatie | MBH_313_4 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_4_TA_2 | ||
Afspraakdatum | T- 222 dagen, om 09:54 | ||
Gebruiksperiode | Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59 | ||
Stoptype | Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_313_4_MA_2 | ||
MBH identificatie | MBH_313_4 |
Medicatiegebruik XXX_Cnossen
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_1_MGB_1 | ||
Registratiedatum | 2018-07-06T12:11:00 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf 2018-07-06T00:00:00, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 2018-07-06T00:00:00, tot nader order, Vanaf T-100, tot nader order, 1 maal per dag 1 inhalatie, inhalatie | ||
Toedieningsweg | Inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 dosis | ||
Gerelateerde afspraak : MA | MBH_313_1_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_313_1 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_1_MGB_2 | ||
Registratiedatum | 2018-06-18T15:25:00 | ||
Gebruik indicator | False | ||
Gebruiksperiode | Vanaf 2018-05-08T00:00:00, tot en met 2018-06-18T23:59:00 | ||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 2018-05-08T00:00:00, tot en met 2018-06-18T23:59:00, Vanaf T-100, tot en met T-59, 1 maal per dag 1 dosis, inhalatie | ||
Toedieningsweg | Inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 dosis | ||
Gerelateerde afspraak : MA | MBH_313_1_MA_2 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_313_1 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_2_MGB_1 | ||
Registratiedatum | 2017-04-03T10:19:00 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf 2017-04-03T00:00:00, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 2017-04-03T00:00:00, tot nader order, Vanaf T-500, tot nader order, 1x per dag 1 druppel, in beide ogen | ||
Toedieningsweg | Oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | In beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||
Doseerinstructie | 1 maal per dag 1 druppel | ||
Gerelateerde afspraak : MA | MBH_313_2_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_313_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_2_MGB_2 | ||
Registratiedatum | 2017-08-15T17:54:00 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf 2017-04-03T00:00:00, tot en met 2017-08-15T17:00:00 | ||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 2017-04-03T00:00:00, tot en met 2017-08-15T17:00:00, Vanaf T-500, tot en met T-366 17:00, 1x per dag 1 druppel, in beide ogen | ||
Toedieningsweg | Oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | In beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||
Doseerinstructie | 1 maal per dag 1 druppel | ||
Gerelateerde afspraak : MA | MBH_313_2_MA_2 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_313_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_3_MGB_1 | ||
Registratiedatum | 2018-05-08T12:11:00 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf 2018-05-08T00:00:00, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 2018-05-08T00:00:00, tot nader order, Vanaf T-100, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_313_3_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_313_3 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_3_MGB_2 | ||
Registratiedatum | 2017-08-12T13:54:00 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf 2018-05-08T00:00:00, tot en met 2018-08-11T23:59:00 | ||
Stoptype | Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 2018-05-08T00:00:00, tot en met 2018-08-11T23:59:00, Vanaf T-100, tot en met T-5, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-4 | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_313_3_MA_2 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_313_3 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_4_MGB_1 | ||
Registratiedatum | 2017-10-20T14:23:00 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf 2017-10-20T00:00:00, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 2017-10-20T00:00:00, tot nader order, Vanaf T-300, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_313_4_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_313_4 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_313_4_MGB_2 | ||
Registratiedatum | 2018-01-06T08:54:00 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf 2017-10-20T00:00:00, tot en met 2018-01-05T23:59:00 | ||
Stoptype | Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 2017-10-20T00:00:00, tot en met 2018-01-05T23:59:00, Vanaf T-300, tot en met T-223, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken vanaf T-222 | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_313_4_MA_2 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_313_4 |
Patiënt R. XXX_Dirksz
Patiënt | |||
Gegevenselement | Waarde | ||
Naamgegevens | R. XXX_Dirksz | ||
Patient identificatienummer | 999911326 [BSN] | ||
Patient identificatienummer | 11101 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 1 aug 1964 | ||
Geslacht | Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Dirksz
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_1_MA_1 | ||
Afspraakdatum | T- 50 dagen, om 11:25 | ||
Gebruiksperiode | Vanaf T- 50 dagen, gedurende 30 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 50 dagen, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | ||
Toedieningsweg | Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | Zo nodig 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_113_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_2_MA_1 | ||
Afspraakdatum | T- 30 dagen, om 14:55 | ||
Gebruiksperiode | Vanaf T- 30 dagen, gedurende 3 weken | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_113_2 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_3_MA_1 | ||
Afspraakdatum | T- 30 dagen, om 14:57 | ||
Gebruiksperiode | Vanaf T- 30 dagen, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 30 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_113_3 |
Verstrekkingsverzoeken XXX_Dirksz
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_1_VV_1 | ||
Datum | T- 50 dagen, om 11:25 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 30 stuks | ||
Geneesmiddel | Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Relatie naar medicatieafspraak | MBH_113_1_MA_1 | ||
MBH identificatie | MBH_113_1 |
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_2_VV_1 | ||
Datum | T- 30 dagen, om 14:55 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 21 stuks | ||
Geneesmiddel | Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Relatie naar medicatieafspraak | MBH_113_2_MA_1 | ||
MBH identificatie | MBH_113_2 |
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_3_VV_1 | ||
Datum | T- 30 dagen, om 14:57 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 21 stuks | ||
Geneesmiddel | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Relatie naar medicatieafspraak | MBH_113_3_MA_1 | ||
MBH identificatie | MBH_113_3 |
Toedieningsafspraken XXX_Dirksz
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_1_TA_1 | ||
Afspraakdatum | T- 50 dagen, om 11:25 | ||
Gebruiksperiode | Vanaf T- 50 dagen, gedurende 30 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | PRIMPERAN ZETPIL 20MG (code = '229709' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 50 dagen, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal | ||
Toedieningsweg | Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | Zo nodig 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_113_1_MA_1 | ||
MBH identificatie | MBH_113_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_2_TA_1 | ||
Afspraakdatum | T- 30 dagen, om 14:55 | ||
Gebruiksperiode | Vanaf T- 30 dagen, gedurende 3 weken | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_113_2_MA_1 | ||
MBH identificatie | MBH_113_2 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_3_TA_1 | ||
Afspraakdatum | T- 30 dagen, om 14:57 | ||
Gebruiksperiode | Vanaf T- 30 dagen, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 30 dagen, tot nader order, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_113_2_MA_1 | ||
MBH identificatie | MBH_113_3 |
Verstrekkingen XXX_Dirksz
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_1_MVE_1 | ||
Datum | T- 50 dagen, om 12:25 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | PRIMPERAN ZETPIL 20MG (code = '229709' in codeSystem 'G-Standaard HPK') | ||
Relatie naar verstrekkingsverzoek | MBH_113_1_VV_1 | ||
MBH identificatie | MBH_113_1 |
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_2_MVE_1 | ||
Datum | T- 30 dagen, om 15:55 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 25 stuks | ||
Geneesmiddel | Zestril tablet 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | ||
Relatie naar verstrekkingsverzoek | MBH_113_2_VV_1 | ||
MBH identificatie | MBH_113_2 |
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_3_MVE_1 | ||
Datum | T- 30 dagen, om 15:56 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 21 stuks | ||
Geneesmiddel | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
Relatie naar verstrekkingsverzoek | MBH_113_3_VV_1 | ||
MBH identificatie | MBH_113_3 |
Medicatiegebruik XXX_Dirksz
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_1_MGB_1 | ||
Registratiedatum | T- 48 dagen, om 11:25 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T- 48 dagen, gedurende 1 dag | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 48 dagen, gedurende 1 dag, zo nodig 1 maal per dag 1 stuk, rectaal | ||
Toedieningsweg | Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | Zo nodig 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_113_1_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_113_1 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_2_MGB_1 | ||
Registratiedatum | T- 13 dagen, om 14:55 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
Gebruiksperiode | Vanaf T- 30 dagen, gedurende 3 weken | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_113_2_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_113_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_113_3_MGB_1 | ||
Registratiedatum | T- 29 dagen, om 14:57 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T- 29 dagen, tot en met T- 8 dagen, om 23:59 | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 29 dagen, tot en met T- 8 dagen, om 23:59, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_113_3_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_113_3 |
Patiënt R. XXX_Gobee
Patiënt | |||
Gegevenselement | Waarde | ||
Naamgegevens | R. XXX_Gobee | ||
Patient identificatienummer | 999911314 [BSN] | ||
Patient identificatienummer | 21104 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 1 aug 1964 | ||
Geslacht | Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Gobee
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MA_1 | ||
Afspraakdatum | T- 50 dagen, om 11:25 | ||
Gebruiksperiode | Vanaf T- 50 dagen, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 50 dagen, tot nader order, 1 à 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
MBH identificatie | MBH_213_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MA_2 | ||
Afspraakdatum | T- 40 dagen, om 09:13 | ||
Gebruiksperiode | Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59 | ||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
Relatie naar afspraak of gebruik: MA | MBH_213_1_MA_1 | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59, 1 à 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
MBH identificatie | MBH_213_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MA_3 | ||
Afspraakdatum | T- 40 dagen, om 09:13 | ||
Gebruiksperiode | Vanaf T- 40 dagen, gedurende 30 dagen | ||
Relatie naar afspraak of gebruik: MA | MBH_213_1_MA_2 | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Geen of onvoldoende effect (code = '5' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 40 dagen, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per dag 1 stuk | ||
MBH identificatie | MBH_213_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MA_4 | ||
Afspraakdatum | T- 15 dagen, om 09:13 | ||
Gebruiksperiode | Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59 | ||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
Relatie naar afspraak of gebruik: MA | MBH_213_1_MA_3 | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59, 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per dag 1 stuk | ||
MBH identificatie | MBH_213_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MA_5 | ||
Afspraakdatum | T- 15 dagen, om 16:25 | ||
Gebruiksperiode | Vanaf T- 14 dagen, gedurende 30 dagen | ||
Relatie naar afspraak of gebruik: MA | MBH_213_1_MA_4 | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Wens patiënt (code = '12' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 14 dagen, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_213_1 |
Verstrekkingsverzoeken XXX_Gobee
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_VV_1 | ||
Datum | T- 50 dagen, om 11:25 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 40 stuks | ||
Aantal herhalingen | 1 | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Relatie naar medicatieafspraak | MBH_213_1_MA_1 | ||
MBH identificatie | MBH_213_1 |
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_VV_2 | ||
Datum | T- 40 dagen, om 09:13 | ||
Auteur | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 60 stuks | ||
Aantal herhalingen | 1 | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Relatie naar medicatieafspraak | MBH_213_1_MA_3 | ||
MBH identificatie | MBH_213_1 |
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_VV_3 | ||
Datum | T- 15 dagen, om 16:25 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Verbruiksperiode | Tot nader order | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Relatie naar medicatieafspraak | MBH_213_1_MA_5 | ||
MBH identificatie | MBH_213_1 |
Toedieningsafspraken XXX_Gobee
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_TA_1 | ||
Afspraakdatum | T- 50 dagen, om 11:25 | ||
Gebruiksperiode | Vanaf T- 50 dagen, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 50 dagen, tot nader order, 1 à 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_213_1_MA_1 | ||
MBH identificatie | MBH_213_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_TA_2 | ||
Afspraakdatum | T- 40 dagen, om 09:13 | ||
Gebruiksperiode | Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59 | ||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59, 1 à 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_213_1_MA_2 | ||
MBH identificatie | MBH_213_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_TA_3 | ||
Afspraakdatum | T- 40 dagen, om 09:13 | ||
Gebruiksperiode | Vanaf T- 40 dagen, gedurende 30 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 40 dagen, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_213_1_MA_3 | ||
MBH identificatie | MBH_213_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_TA_4 | ||
Afspraakdatum | T- 15 dagen, om 09:13 | ||
Gebruiksperiode | Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59 | ||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59, 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_213_1_MA_4 | ||
MBH identificatie | MBH_213_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_TA_5 | ||
Afspraakdatum | T- 15 dagen, om 16:25 | ||
Gebruiksperiode | Vanaf T- 14 dagen, gedurende 30 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 14 dagen, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_213_1_MA_5 | ||
MBH identificatie | MBH_213_1 |
Verstrekkingen XXX_Gobee
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MVE_1 | ||
Datum | T- 50 dagen, om 13:25 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 40 stuks | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Relatie naar verstrekkingsverzoek | MBH_213_1_VV_1 | ||
MBH identificatie | MBH_213_1 |
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MVE_2 | ||
Datum | T- 40 dagen, om 09:13 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 60 stuks | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Relatie naar verstrekkingsverzoek | MBH_213_1_VV_2 | ||
MBH identificatie | MBH_213_1 |
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MVE_3 | ||
Datum | T- 15 dagen, om 17:25 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 30 stuks | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK') | ||
Verbruiksduur | 30 dagen | ||
Relatie naar verstrekkingsverzoek | MBH_213_1_VV_2 | ||
MBH identificatie | MBH_213_1 |
Medicatiegebruik XXX_Gobee
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MGB_1 | ||
Registratiedatum | T- 47 dagen, om 11:25 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T- 50 dagen, gedurende 3 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 50 dagen, gedurende 3 dagen, 1 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_213_1_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_213_1 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MGB_2 | ||
Registratiedatum | T- 41 dagen, om 11:25 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T- 46 dagen, gedurende 6 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 46 dagen, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_213_1_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_213_1 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MGB_3 | ||
Registratiedatum | T- 35 dagen, om 19:25 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T- 40 dagen, gedurende 6 dagen | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 40 dagen, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per dag 1 stuk | ||
Gerelateerde afspraak : TA | MBH_213_1_TA_3 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_213_1 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MGB_4 | ||
Registratiedatum | T- 16 dagen, om 11:25 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T- 34 dagen, gedurende 19 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 34 dagen, gedurende 19 dagen, 2 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_213_1_MA_3 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_213_1 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_213_1_MGB_5 | ||
Registratiedatum | T- 10 dagen, om 11:25 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T- 14 dagen, gedurende 5 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 14 dagen, gedurende 5 dagen, 1 maal per dag 1 tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_213_1_MA_5 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_213_1 |
Patiënt J. XXX_Kilkenny
Patiënt | |||
Gegevenselement | Waarde | ||
Naamgegevens | J. XXX_Kilkenny | ||
Patient identificatienummer | 999911752 [BSN] | ||
Patient identificatienummer | 22108 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 5 aug 1964 | ||
Geslacht | Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Kilkenny
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_323_1_MA_1 | ||
Afspraakdatum | T- 5 dagen, om 15:34 | ||
Gebruiksperiode | Vanaf T- 20 dagen, tot en met T- 6 dagen, om 23:59 | ||
Stoptype | Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1') | ||
Voorschrijver | John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 20 dagen, tot en met T- 6 dagen, om 23:59, 3x per dag 1 tablet | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
MBH identificatie | MBH_323_1 |
Medicatiegebruik XXX_Kilkenny
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_323_1_MGB_1 | ||
Registratiedatum | T- 10 dagen, om 11:25 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T- 20 dagen, tot nader order | ||
Geneesmiddel | ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 20 dagen, tot nader order, 3x per dag 1 tablet | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_323_1 |
Patiënt R. XXX_Ruys
Patiënt | |||
Gegevenselement | Waarde | ||
Naamgegevens | R. XXX_Ruys | ||
Patient identificatienummer | 999911351 [BSN] | ||
Patient identificatienummer | 13103 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 1 aug 1964 | ||
Geslacht | Man (code = 'M' in codeSystem '2.16.840.1.113883.5.1') |
Patiënt R. XXX_Strengersz
Patiënt | |||
Gegevenselement | Waarde | ||
Naamgegevens | R. XXX_Strengersz | ||
Patient identificatienummer | 999911338 [BSN] | ||
Patient identificatienummer | 41106 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' | ||
Geboortedatum | 1 aug 1964 | ||
Geslacht | Vrouw (code = 'F' in codeSystem '2.16.840.1.113883.5.1') |
Medicatieafspraken XXX_Strengersz
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_1_MA_1 | ||
Afspraakdatum | T, om 11:25 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
MBH identificatie | MBH_413_1 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_2_MA_1 | ||
Afspraakdatum | T, om 11:25 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-StandaardGPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | Exact iedere 3 uur 16 internationale eenheid | ||
MBH identificatie | MBH_413_2 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_3_MA_1 | ||
Afspraakdatum | T- 50 dagen, om 11:25 | ||
Gebruiksperiode | Vanaf T- 50 dagen, gedurende 7 weken | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 50 dagen, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 à 2 stuks | ||
MBH identificatie | MBH_413_3 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_4_MA_1 | ||
Afspraakdatum | T- 20 dagen, om 10:26 | ||
Gebruiksperiode | Vanaf T- 20 dagen, gedurende 30 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-StandaardGPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 20 dagen, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | ||
Toedieningsweg | Cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Doseerinstructie | 3 maal per dag | ||
MBH identificatie | MBH_413_4 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_5_MA_1 | ||
Afspraakdatum | T- 20 dagen, om 10:46 | ||
Gebruiksperiode | Vanaf T- 20 dagen, gedurende 30 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Ibuprofen PCH tablet 600mg (code = '641898' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 20 dagen, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per dag 0.25 stuk | ||
MBH identificatie | MBH_413_5 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_6_MA_1 | ||
Afspraakdatum | T, om 09:35 | ||
Gebruiksperiode | Vanaf T, gedurende 14 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Waterstofperoxide 30MG/ML (code = '67016' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
Toedieningsweg | Niet van toepassing (code = '1' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Aanvullende instructie | Mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Doseerinstructie | 2 maal per dag 10 à 15 ml | ||
MBH identificatie | MBH_413_6 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_7_MA_1 | ||
Afspraakdatum | T, om 09:35 | ||
Gebruiksperiode | Vanaf T, gedurende 14 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid | ||
MBH identificatie | MBH_413_7 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_8_MA_1 | ||
Afspraakdatum | T, om 09:35 | ||
Gebruiksperiode | Vanaf T, gedurende 10 weken | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | Voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Aanvullende instructie | Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Doseerinstructie | Op maandag, woensdag en vrijdag | ||
MBH identificatie | MBH_413_8 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_9_MA_1 | ||
Afspraakdatum | T, om 09:35 | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk 's avonds | ||
MBH identificatie | MBH_413_9 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_10_MA_1 | ||
Afspraakdatum | T, om 09:35 | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | Gedurende 21 dagen 1 maal per dag 1 stuk | ||
Herhaalperiode cyclisch schema | 28 dagen | ||
MBH identificatie | MBH_413_10 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_11_MA_1 | ||
Afspraakdatum | T, om 09:35 | ||
Gebruiksperiode | Vanaf T, gedurende 41 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
Toedieningsweg | Cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | Dun aanbrengen (code = '1033' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||
Doseerinstructie 1 | Eerst gedurende 2 weken 1 maal per dag 3 gram | ||
Doseerinstructie 2 | Dan gedurende 3 weken 1 maal per dag 2 gram | ||
Doseerinstructie 3 | Dan gedurende 6 dagen 1 maal per dag 1 gram | ||
MBH identificatie | MBH_413_11 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_12_MA_1 | ||
Afspraakdatum | T, om 11:25 | ||
Gebruiksperiode | Vanaf T, gedurende 3 weken | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | Bij hoest 3 à 4 maal per uur 1 stuk | ||
MBH identificatie | MBH_413_12 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_13_MA_1 | ||
Afspraakdatum | T- 28 dagen, om 09:12 | ||
Gebruiksperiode | Vanaf T- 28 dagen, gedurende 8 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 28 dagen, gedurende 8 dagen, 0.5 ml per uur parenteraal | ||
Toedieningsweg | Parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 0.5 ml per uur | ||
MBH identificatie | MBH_413_13 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_13_MA_2 | ||
Afspraakdatum | T- 20 dagen, om 11:25 | ||
Gebruiksperiode | Vanaf T- 20 dagen, gedurende 8 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 20 dagen, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | ||
Toedieningsweg | Parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 0.2 à 0.5 ml per uur | ||
MBH identificatie | MBH_413_13 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_14_MA_1 | ||
Afspraakdatum | T, om 11:25 | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | ||
Toedieningsweg | Transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk gedurende 16 uur | ||
MBH identificatie | MBH_413_14 |
Medicatieafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_15_MA_1 | ||
Afspraakdatum | T, om 09:35 | ||
Gebruiksperiode | Vanaf T, gedurende 4 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Reden afspraak | Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel - Product specificatie | |||
Product naam | Haparine 100 ie= 10 ml | ||
Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
Farmaceutische vorm | Vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') | ||
Ingredient | |||
Ingredient code | Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||
Sterkte | 100 internationale eenheid per 10 ml | ||
Ingredient | |||
Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||
Sterkte | 1 stuk per 10 ml | ||
Ingredient | |||
Ingredient code | NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | ||
Sterkte | 0.09 gram per 10 ml | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | ||
Toedieningsweg | Parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per dag 10 ml | ||
MBH identificatie | MBH_413_15 |
Verstrekkingsverzoeken XXX_Strengersz
Verstrekkingsverzoek | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_15_VV_1 | ||
Datum | T, om 09:35 | ||
Auteur | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Te verstrekken hoeveelheid | 100 ml | ||
Aantal herhalingen | 1 | ||
Geneesmiddel - Product specificatie | |||
Product naam | Haparine 100 ie= 10 ml | ||
Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
Farmaceutische vorm | Vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') | ||
Ingredient | |||
Ingredient code | Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||
Sterkte | 100 internationale eenheid per 10 ml | ||
Ingredient | |||
Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||
Sterkte | 1 stuk per 10 ml | ||
Ingredient | |||
Ingredient code | NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | ||
Sterkte | 0.09 gram per 10 ml | ||
Beoogd verstrekker | Apotheek De Gulle Gaper | ||
Relatie naar medicatieafspraak | MBH_413_15_MA_1 | ||
MBH identificatie | MBH_413_15 |
Toedieningsafspraken XXX_Strengersz
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_1_TA_1 | ||
Afspraakdatum | T, om 11:25 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-StandaardGPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
Relatie naar medicatieafspraak | MBH_413_1_MA_1 | ||
MBH identificatie | MBH_413_1 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_2_TA_1 | ||
Afspraakdatum | T, om 11:25 | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471' in codeSystem 'G-StandaardGPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | Exact iedere 3 uur 16 internationale eenheid | ||
Relatie naar medicatieafspraak | MBH_413_2_MA_1 | ||
MBH identificatie | MBH_413_2 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_3_TA_1 | ||
Afspraakdatum | T- 50 dagen, om 11:25 | ||
Gebruiksperiode | Vanaf T- 50 dagen, gedurende 7 weken | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-StandaardGPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 50 dagen, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 à 2 stuks | ||
Relatie naar medicatieafspraak | MBH_413_3_MA_1 | ||
MBH identificatie | MBH_413_3 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_4_TA_1 | ||
Afspraakdatum | T- 20 dagen, om 10:26 | ||
Gebruiksperiode | Vanaf T- 20 dagen, gedurende 30 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-StandaardGPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 20 dagen, gedurende 30 dagen, 3 maal per dag aanbrengen, cutaan | ||
Toedieningsweg | Cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Doseerinstructie | 3 maal per dag | ||
Relatie naar medicatieafspraak | MBH_413_4_MA_1 | ||
MBH identificatie | MBH_413_4 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_5_TA_1 | ||
Afspraakdatum | T- 20 dagen, om 10:46 | ||
Gebruiksperiode | Vanaf T- 20 dagen, gedurende 30 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | Ibuprofen PCH tablet 600mg (code = '641898' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 20 dagen, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per dag 0.25 stuk | ||
Relatie naar medicatieafspraak | MBH_413_5_MA_1 | ||
MBH identificatie | MBH_413_5 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_6_TA_1 | ||
Afspraakdatum | T, om 09:35 | ||
Gebruiksperiode | Vanaf T, gedurende 14 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | SOLUTIO HYDROGENII PEROXIDI 3% M/V (code = '603694' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 14 dagen, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
Toedieningsweg | Niet van toepassing (code = '1' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Aanvullende instructie | Mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Doseerinstructie | 2 maal per dag 10 à 15 ml | ||
Relatie naar medicatieafspraak | MBH_413_6_MA_1 | ||
MBH identificatie | MBH_413_6 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_7_TA_1 | ||
Afspraakdatum | T, om 09:35 | ||
Gebruiksperiode | Vanaf T, gedurende 14 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | HUMULINE NPH INJ 100IE/ML PATROON 3ML (code = '870471' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 14 dagen, elke dag om 08:00, 14:00 en 20:00 uur 16IE | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | Elke dag om 08:00, 14:00 en 20:00 16 internationale eenheid | ||
Relatie naar medicatieafspraak | MBH_413_7_MA_1 | ||
MBH identificatie | MBH_413_7 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_8_TA_1 | ||
Afspraakdatum | T, om 09:35 | ||
Gebruiksperiode | Vanaf T, gedurende 10 weken | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | Voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Aanvullende instructie | Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Doseerinstructie | Op maandag, woensdag en vrijdag | ||
Relatie naar medicatieafspraak | MBH_413_8_MA_1 | ||
MBH identificatie | MBH_413_8 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_9_TA_1 | ||
Afspraakdatum | T, om 09:35 | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk 's avonds | ||
Relatie naar medicatieafspraak | MBH_413_9_MA_1 | ||
MBH identificatie | MBH_413_9 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_10_TA_1 | ||
Afspraakdatum | T, om 09:35 | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | Gedurende 21 dagen 1 maal per dag 1 stuk | ||
Herhaalperiode cyclisch schema | 28 dagen | ||
Relatie naar medicatieafspraak | MBH_413_10_MA_1 | ||
MBH identificatie | MBH_413_10 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_11_TA_1 | ||
Afspraakdatum | T, om 09:35 | ||
Gebruiksperiode | Vanaf T, gedurende 41 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | FUCIDIN CREME 20MG/G (code = '420956' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
Toedieningsweg | Cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | Dun aanbrengen (code = '1033' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||
Doseerinstructie 1 | Eerst gedurende 2 weken 1 maal per dag 3 gram | ||
Doseerinstructie 2 | Dan gedurende 3 weken 1 maal per dag 2 gram | ||
Doseerinstructie 3 | Dan gedurende 6 dagen 1 maal per dag 1 gram | ||
Relatie naar medicatieafspraak | MBH_413_11_MA_1 | ||
MBH identificatie | MBH_413_11 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_12_TA_1 | ||
Afspraakdatum | T, om 11:25 | ||
Gebruiksperiode | Vanaf T, gedurende 3 weken | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | Bij hoest 3 à 4 maal per uur 1 stuk | ||
Relatie naar medicatieafspraak | MBH_413_12_MA_1 | ||
MBH identificatie | MBH_413_12 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_13_TA_1 | ||
Afspraakdatum | T- 28 dagen, om 09:12 | ||
Gebruiksperiode | Vanaf T- 28 dagen, gedurende 8 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 28 dagen, gedurende 8 dagen, 0.5 ml per uur parenteraal | ||
Toedieningsweg | Parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 0.5 ml per uur | ||
Relatie naar medicatieafspraak | MBH_413_13_MA_1 | ||
MBH identificatie | MBH_413_13 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_13_TA_2 | ||
Afspraakdatum | T- 20 dagen, om 11:25 | ||
Gebruiksperiode | Vanaf T- 20 dagen, gedurende 8 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | MORFINEHYDROCHLORIDE 5MG/ML DELTEC CAS 100ML PA (code = '2124823' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 20 dagen, gedurende 8 dagen, 0.2 tot 0.5 ml per uur parenteraal | ||
Toedieningsweg | Parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 0.2 à 0.5 ml per uur | ||
Relatie naar medicatieafspraak | MBH_413_13_MA_2 | ||
MBH identificatie | MBH_413_13 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_14_TA_1 | ||
Afspraakdatum | T, om 11:25 | ||
Gebruiksperiode | Vanaf 2018-08-16T00:00:00, tot nader order | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel | DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf 2018-08-16T00:00:00, tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | ||
Toedieningsweg | Transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk gedurende 16 uur | ||
Relatie naar medicatieafspraak | MBH_413_14_MA_1 | ||
MBH identificatie | MBH_413_14 |
Toedieningsafspraak | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_15_TA_1 | ||
Afspraakdatum | T, om 09:35 | ||
Gebruiksperiode | Vanaf T, gedurende 4 dagen | ||
Verstrekker | Apotheek De Gulle Gaper | ||
Geneesmiddel - Product specificatie | |||
Product naam | Haparine 100 ie= 10 ml | ||
Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
Farmaceutische vorm | Vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') | ||
Ingredient | |||
Ingredient code | Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||
Sterkte | 100 internationale eenheid per 10 ml | ||
Ingredient | |||
Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||
Sterkte | 1 stuk per 10 ml | ||
Ingredient | |||
Ingredient code | NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | ||
Sterkte | 0.09 gram per 10 ml | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | ||
Toedieningsweg | Parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per dag 10 ml | ||
Relatie naar medicatieafspraak | MBH_413_15_MA_1 | ||
MBH identificatie | MBH_413_15 |
Verstrekkingen XXX_Strengersz
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_9_MVE_1 | ||
Datum | T, om 10:35 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 90 stuks | ||
Geneesmiddel | INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') | ||
Distributievorm | Geïndividualiseerd distributiesysteem (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') | ||
MBH identificatie | MBH_413_9 |
Verstrekking | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_15_MVE_1 | ||
Datum | T, om 10:35 | ||
Verstrekker | Apotheek de Gulle Gaper | ||
Verstrekte hoeveelheid | 100 ml | ||
Geneesmiddel - Product specificatie | |||
Product naam | Haparine 100 ie= 10 ml | ||
Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
Farmaceutische vorm | Vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') | ||
Ingredient | |||
Ingredient code | Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||
Sterkte | 100 internationale eenheid per 10 ml | ||
Ingredient | |||
Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||
Sterkte | 1 stuk per 10 ml | ||
Ingredient | |||
Ingredient code | NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | ||
Sterkte | 0.09 gram per 10 ml | ||
Relatie naar verstrekkingsverzoek | MBH_513_15_VV_1 | ||
MBH identificatie | MBH_413_15 |
Medicatiegebruik XXX_Strengersz
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_1_MGB_1 | ||
Registratiedatum | T, om 16:25 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
Gebruiksperiode | Vanaf T, gedurende 60 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
Gerelateerde afspraak : MA | MBH_413_1_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_1 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_2_MGB_1 | ||
Registratiedatum | T, om 14:25 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T, gedurende 14 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-StandaardGPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 14 dagen, exact iedere 3 uur 16 IE, subcutaan | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | Exact iedere 3 uur 16 internationale eenheid | ||
Gerelateerde afspraak : MA | MBH_413_2_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_2 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_3_MGB_1 | ||
Registratiedatum | T, om 10:45 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
Gebruiksperiode | Vanaf T- 50 dagen, gedurende 7 weken | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-StandaardGPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 50 dagen, gedurende 7 weken, 3 maal per dag 1 à 2 stuks, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 à 2 stuks | ||
Gerelateerde afspraak : MA | MBH_413_3_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_3 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_4_MGB_1 | ||
Registratiedatum | T- 15 dagen, om 13:44 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T- 20 dagen, tot en met T- 15 dagen, om 23:59 | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-StandaardGPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 20 dagen, tot en met T- 15 dagen, om 23:59, 3 maal per dag aanbrengen, cutaan | ||
Toedieningsweg | Cutaan (code = '7' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Doseerinstructie | 3 maal per dag | ||
Gerelateerde afspraak : MA | MBH_413_4_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_4 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_5_MGB_1 | ||
Registratiedatum | T, om 12:38 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T- 20 dagen, gedurende 30 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Ibuprofen PCH tablet 600mg (code = '641898' in codeSystem 'G-Standaard HPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T- 20 dagen, gedurende 30 dagen, 2 maal per dag ¼ tablet, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per dag 0.25 stuk | ||
Gerelateerde afspraak : MA | MBH_413_5_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_5 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_6_MGB_1 | ||
Registratiedatum | T, om 21:37 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T, gedurende 1 dag | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Waterstofperoxide 30MG/ML (code = '67016' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 1 dag, 2x per dag 10 tot 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen | ||
Toedieningsweg | Niet van toepassing (code = '1' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Aanvullende instructie | Mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Doseerinstructie | 2 maal per dag 10 à 15 ml | ||
Gerelateerde afspraak : MA | MBH_413_6_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_6 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_7_MGB_1 | ||
Registratiedatum | T, om 14:05 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T, om 14:00, tot en met T, om 14:05 | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, om 14:00, tot en met T, om 14:05, om 14:00 16IE | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | Elke dag om 16 internationale eenheid | ||
Gerelateerde afspraak : MA | MBH_413_7_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_7 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_7_MGB_2 | ||
Registratiedatum | T, om 20:10 | ||
Gebruik indicator | True | ||
Gebruiksperiode | Vanaf T, om 20:00, tot en met T, om 20:05 | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Insuline isofaan injsusp 100ie/ml patr 3ml (code = '34851' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, om 20:00, tot en met T, om 20:05, om 20:00 16IE | ||
Toedieningsweg | Subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | Elke dag om 16 internationale eenheid | ||
Gerelateerde afspraak : MA | MBH_413_7_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_7 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_8_MGB_1 | ||
Registratiedatum | T, om 23:59 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
Gebruiksperiode | Vanaf T, gedurende 10 weken | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 10 weken, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan | ||
Aanvullende instructie | Voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Aanvullende instructie | Aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Doseerinstructie | Op maandag, woensdag en vrijdag | ||
Gerelateerde afspraak : MA | MBH_413_8_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_8 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_9_MGB_1 | ||
Registratiedatum | T, om 22:35 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, 1 maal daags 1 stuk ’s avonds innemen, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk 's avonds | ||
Gerelateerde afspraak : MA | MBH_413_9_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_9 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_10_MGB_1 | ||
Registratiedatum | T, om 09:35 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
Gebruiksperiode | Vanaf T, tot nader order | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Ethinyl estradiol/desogestrel tablet 30/150ug (Marvelon) (code = '16292' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot nader order, cyclus van 28 dagen: steeds 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal | ||
Doseerinstructie | Gedurende 21 dagen 1 maal per dag 1 stuk | ||
Herhaalperiode cyclisch schema | 28 dagen | ||
Gerelateerde afspraak : MA | MBH_413_10_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_10 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_11_MGB_1 | ||
Registratiedatum | T, om 15:35 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
Gebruiksperiode | Vanaf T, gedurende 41 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 41 dagen, eerst 2 weken 3gr per dag, dan 3 weken 2gr per dag, dan 6 dagen 1gr per dag, dun aanbrengen, cutaan | ||
Aanvullende instructie | Dun aanbrengen (code = '1033' in codeSystem 'NHG tabel 25 aanvullende teksten') | ||
Doseerinstructie 1 | Eerst gedurende 2 weken 1 maal per dag 3 gram | ||
Doseerinstructie | Dan gedurende 3 weken 1 maal per dag 2 gram | ||
Doseerinstructie | Dan gedurende 6 dagen 1 maal per dag 1 gram | ||
Gerelateerde afspraak : MA | MBH_413_11_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_11 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_12_MGB_1 | ||
Registratiedatum | T, om 22:35 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
Gebruiksperiode | Vanaf T, gedurende 3 weken | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 3 weken, iedere 3 à 4 uur 1 stuk bij hoest, maximaal 6 stuks per dag, oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | Bij hoest 3 à 4 maal per uur 1 stuk | ||
Gerelateerde afspraak : MA | MBH_413_12_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_12 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_14_MGB_1 | ||
Registratiedatum | T, om 22:35 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | ||
Gebruiksinstructie | |||
Omschrijving | Tot nader order, eenmaal daags 1 pleister aanbrengen gedurende 16 uur (daarna 8 uur geen pleister), transdermaal | ||
Toedieningsweg | Transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk gedurende 16 uur | ||
Gerelateerde afspraak : MA | MBH_413_14_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_14 |
Medicatie gebruik | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_413_15_MGB_1 | ||
Registratiedatum | T, om 10:35 | ||
Gebruik indicator | True | ||
Volgens afspraak indicator | True | ||
Gebruiksperiode | Vanaf T, gedurende 4 dagen | ||
Voorschrijver | Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | ||
Geneesmiddel - Product specificatie | |||
Product naam | Haparine 100 ie= 10 ml | ||
Omschrijving | Titel: Haparine 100 ie= 10 ml Regel: Minpl cla water c ing 10ml Regel: Heparini natricum Regel: natrri chloridum | ||
Farmaceutische vorm | Vloeistof (code = '434' in codeSystem 'G-Standaard Farmaceutische vormen (tabel 6)') | ||
Ingredient | |||
Ingredient code | Heparinum natricum (code = '898724' in codeSystem 'G-Standaard HPK') | ||
Sterkte | 100 internationale eenheid per 10 ml | ||
Ingredient | |||
Ingredient code | WATER VOOR INJECTIE CF FLACON 10ML (code = '2257610' in codeSystem 'G-Standaard HPK') | ||
Sterkte | 1 stuk per 10 ml | ||
Ingredient | |||
Ingredient code | NATRII CHLORIDUM (code = '256390' in codeSystem 'G-Standaard HPK') | ||
Sterkte | 0.09 gram per 10 ml | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, gedurende 4 dagen, 2 maal per dag 10 ml, parenteraal | ||
Toedieningsweg | Parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per dag 10 ml | ||
Gerelateerde afspraak : MA | MBH_413_15_MA_1 | ||
Auteur | Patiënt | ||
MBH identificatie | MBH_413_15 |